Effect of Glucagon-Like Peptide 1(7-36) Amide on Glucose Effectiveness and Insulin Action in People With Type 2 Diabetes

Diabetes - United States
doi 10.2337/diabetes.49.4.611
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Normalization of Fasting Hyperglycaemia by Exogenous Glucagon-Like Peptide 1 (7-36 Amide) in Type 2 (Non-Insulin-Dependent) Diabetic Patients

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1993English

Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1996English

Effects of Glucagon-Like Peptide-1(7-36)amide on Motility and Sensation of the Proximal Stomach in Humans

Gut
Gastroenterology
2002English

Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Effect of Targeted Estrogen Delivery Using Glucagon-Like Peptide-1 on Insulin Secretion, Insulin Sensitivity and Glucose Homeostasis

Scientific Reports
Multidisciplinary
2015English

Effects of Glucagon-Like Peptide-1-(7–36)-Amide on Pancreatic Islet and Intestinal Blood Perfusion in Wistar Rats and Diabetic GK Rats

Clinical Science
Medicine
2007English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Effect of Intraportal Glucagon-Like Peptide-1 on Glucose Metabolism in Conscious Dogs

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2003English

Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy